Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. 1998

J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
Department of Pediatrics, University of Geneva, Switzerland. jon@pog.ufl.edu

OBJECTIVE In childhood B-precursor acute lymphoblastic leukemia (ALL), possible interactions among sex, time, and widely used prognostic factors (age, WBC count, and DNA index) were investigated for the first 5 years after diagnosis. METHODS All eligible patients aged 1 to less than 22 years, registered between February 1986 and September 1994 in two B-precursor ALL studies from the Pediatric Oncology Group (POG), were included in the analysis. Cutpoints for age (3.0, 5.0, and 10.0 years), WBC count (10, 50, and 100 x 10(9)/L), and DNA index (DI; 1.16) were defined. Four time periods after diagnosis (years 1, 2, 3, and 4 and 5 combined) were selected for the study of prognostic significance over time. The cut-off date for analysis was April 1996. RESULTS A total of 3,717 children (2,010 boys and 1,707 girls) were included in the outcome analysis. No major differences between the sexes were observed in age, duration of symptoms before registration, WBC count, hemoglobin level, platelet count, ploidy, presence of CNS disease at diagnosis, or induction failure rate. Event-free survival (EFS) differences between sexes became significantly different from 2 years following diagnosis. At 5 years, in all subsets analyzed, boys fared worse than girls, although not all differences were statistically significant. Major sex differences in EFS were observed in older children (10 to 22 years), in patients with intermediate WBC counts (10 to 50 x 10(9)/ L), and in children who fit both of these subgroups, in whom the 2-year EFS was almost 20% higher in girls than in boys, reaching a 38% difference at 5 years. CONCLUSIONS This study shows an outcome interaction among sex, time, and commonly used prognostic variables. The important sex difference observed at 2 and 5 years suggests that more intensive consolidation and/or maintenance therapy in some boys with B-precursor ALL should be investigated.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
June 1997, Blood,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
August 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
February 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
January 1990, Blood,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
June 2007, Cancer genetics and cytogenetics,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
December 1987, Blood,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
November 2006, Blood,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
August 2007, Haematologica,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
January 1998, Journal of pediatric hematology/oncology,
J J Shuster, and P Wacker, and J Pullen, and J Humbert, and V J Land, and D H Mahoney, and S Lauer, and A T Look, and M J Borowitz, and A J Carroll, and B Camitta
July 1994, Blood,
Copied contents to your clipboard!